| 1 |
Corlateanu A, Mendez Y, Wang Y, et al. Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art[J]. Pulmonology, 2020, 26(2): 95-100.
|
| 2 |
Halpin DMG, Criner GJ, Papi A, et al. The 2020 GOLD Science Committee Report on COVID-19 and chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2021, 203(1): 24-36.
|
| 3 |
Duffy SP, Criner GJ. Chronic obstructive pulmonary disease: evaluation and management[J]. Med Clin North Am, 2019, 103(3): 453-461.
|
| 4 |
Celli BR, Wedzicha JA. Update on clinical aspects of Chronic obstructive pulmonary disease[J]. N Engl J Med, 2019, 381(13): 1257-1266.
|
| 5 |
Bonnevie T, Elkins M. Chronic obstructive pulmonary disease[J]. J Physiother, 2020, 66(1): 3-4.
|
| 6 |
Ritchie AI, Wedzicha JA. Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations[J]. Clin Chest Med, 2020, 41(3): 421-438.
|
| 7 |
Sorathia L. Palliative care in chronic obstructive pulmonary disease[J]. Med Clin North Am, 2019, 103(3): 517-526.
|
| 8 |
夏元旦，杜晓梅，周 敏，等. 吸入型长效抗胆碱能药物及吸入型长效β2受体激动剂在慢性阻塞性肺疾病患者中的应用评价[J]. 药学服务与研究，2019, 19(3): 56-58.
|
| 9 |
薛佩妮，冯敏娟，王惠琴. 噻托溴铵粉联合糖皮质激素治疗慢性阻塞性肺疾病疗效及对患者生活质量评分的影响[J]. 陕西医学杂志，2020, 49(2): 216-219.
|
| 10 |
Albertson TE, Bowman WS, Harper RW, et al. Evidence-based review of data on the combination inhaler umeclidinium/vilanterol in patients with COPD[J]. Int J Chron Obstruct Pulmon Dis, 2019, 6(14): 1251-1265.
|
| 11 |
中华医学会，中华医学会杂志社，中华医学会全科医学分会，等．慢性阻塞性肺疾病基层诊疗指南(实践版·2018)[J]. 中华全科医师杂志，2018, 17(11): 871-877.
|
| 12 |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊断指南[J]. 中华结核和呼吸杂志，2013, 36(4): 255-264.
|
| 13 |
朱成华，蔡 璐，安伯萍，等. 慢性阻塞性肺疾病伴认知功能障碍患者血清lipocalin-2表达及意义[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(1): 29-32.
|
| 14 |
Horodinschi RN, Bratu OG, Dediu GN, et al. Heart failure and chronic obstructive pulmonary disease: a review[J]. Acta Cardiol, 2020, 75(2): 97-104.
|
| 15 |
Sakao S. Chronic obstructive pulmonary disease and the early stage of cor pulmonale: A perspective in treatment with pulmonary arterial hypertension-approved drugs[J]. Respir Investig, 2019, 57(4): 325-329.
|
| 16 |
Wouters EF, Posthuma R, Koopman M, et al. An update on pulmonary rehabilitation techniques for patients with chronic obstructive pulmonary disease[J]. Expert Rev Respir Med, 2020 , 14(2): 149-161.
|
| 17 |
任成山，王关嵩，钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
| 18 |
Guerreiro I, Soccal PM. COPD and phenotypes[J]. Rev Med Suisse, 2019, 15(671): 2082-2086.
|
| 19 |
Perez-Padilla R, Menezes AMB. Chronic obstructive pulmonary disease in latin America[J]. Ann Glob Health, 2019, 85(1): 7-10.
|
| 20 |
Cavallazzi R, Ramirez J. Community-acquired pneumonia in chronic obstructive pulmonary disease[J]. Curr Opin Infect Dis, 2020, 33(2): 173-181.
|
| 21 |
Li T, Gao L, Ma HX, et al. Clinical value of IL-13 and ECP in the serum and sputum of eosinophilic AECOPD patients[J]. Exp Biol Med (Maywood), 2020, 245(14): 1290-1298.
|
| 22 |
Cole JL, Smith S. Provider perceptions on steroid dosing in AECOPD：laying the groundwork for steroid stewardship[J]. Clin Respir J, 2020, 14(11): 1105-1108.
|
| 23 |
Di J, Li X, Xie Y, et al. Procalcitonin-guided antibiotic therapy in AECOPD patients: overview of systematic reviews[J]. Clin Respir J, 2021, 15(6): 579-594.
|
| 24 |
Qu F, Liu F, Zhang H, et al. Comparison of air pollutant-related hospitalization burden from AECOPD in Shijiazhuang, China, between heating and non-heating season[J]. Environ Sci Pollut Res Int, 2019, 26(30): 31225-31233.
|
| 25 |
Ferguson GT, Darken P, Ballal S, et al. Efficacy of budesonide/glycopyrronium/formoterol fumarate metered dose inhaler (BGF MDI) versus other inhaled corticosteroid/long-acting muscarinic antagonist/long-acting β2-agonist (ICS/LAMA/LABA) triple combinations in COPD: A systematic literature review and network meta-analysis[J]. Adv Ther, 2020, 37(6): 2956-2975.
|
| 26 |
Sliwka A, Jankowski M, Gross-Sondej I, et al. Once-daily long-acting beta2-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease[J]. Cochrane Database Syst Rev, 2018, 8(8): 1235-1237.
|
| 27 |
陈健聪，吴锡平. 糠酸氟替卡松/维兰特罗治疗慢性阻塞性肺疾病的有效性与安全性[J]. 国际呼吸杂志，2018, 38(7): 549-553.
|
| 28 |
户 光，刘梓晗，魏玉娜，等. LABA/LAMA联合治疗中到极重度COPD有效性和安全性的网状Meta分析[J]. 药物流行病学杂志，2020, 29(1): 6-18.
|